Pathological mechanisms in progressive multiple sclerosis.
about
Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionClinical perspectives of TRAIL: insights into central nervous system disordersExploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationStage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisThe Role of Astrocytes in Multiple Sclerosis ProgressionNovel Insights and Therapeutics in Multiple SclerosisKynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous SystemEvaluating the Oxidative Stress in Inflammation: Role of MelatoninGut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune DysregulationThe topographical model of multiple sclerosis: A dynamic visualization of disease courseProlactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesNew Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple SclerosisOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisAutoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosisNudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.Use of natalizumab in multiple sclerosis: current perspectives.Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imagingPrimary Progressive Multiple Sclerosis: Putting Together the PuzzleTherapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microgliaMultiple sclerosis: Pathology, diagnosis and treatments.Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating diseaseReconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.An updated histological classification system for multiple sclerosis lesions.Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.Cell type-specific Nrf2 expression in multiple sclerosis lesions.A potent and selective C-11 labeled PET tracer for imaging sphingosine-1-phosphate receptor 2 in the CNS demonstrates sexually dimorphic expression.Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS)Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Regeneration of myelin sheaths of normal length and thickness in the zebrafish CNS correlates with growth of axons in caliber.Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.
P2860
Q26738329-AF0C6745-4EC0-4EDB-8B68-F2A58710981FQ26766570-B7C47560-BD31-4417-A72E-4F0A10B907FCQ26770818-16D98F4C-C828-4794-820F-F4C3F345E756Q26770852-843CA5C5-A56F-4B3D-96E4-D792C4E71342Q26781529-CD1CE1E0-15E8-4B61-9FA3-6E70B7593AC1Q26782843-BD34E6BB-4CAB-4061-9F9E-0A6BACE86B48Q26784619-D631DBDB-43B8-4321-A5D3-E9AD9F4085A6Q26796667-0CDE10FF-B9CF-432A-91EB-D7079275784DQ26801531-215E31CD-E74C-4A6D-8664-63DDBA4F49A0Q26824638-828D81E2-E286-4F27-8494-2590FCE0CB0EQ27312133-CAE57D67-05D5-4873-8908-DB86B0B73F94Q28068330-B3EF65A1-803B-48CD-AC9F-B310E35EE355Q28068709-6A4EBCA6-856D-48E5-BD18-BD326E8492D5Q28072844-ADD1E2BB-1FCC-4A6E-8C5A-06938D37B3ACQ28076588-14241D17-2021-4E14-A49A-020609F11E55Q28080754-E9E777DC-B1E8-4F37-9623-39184BC2D6D2Q28270642-5AB2A919-654B-4A45-8E4D-70DD81CB73B1Q28586716-8AF030B5-C3FD-40FC-8BE1-ADE2B65CE390Q30355283-B7ABCA66-5FA3-4E4C-A90D-5286FF280A57Q31114633-0F4E7ED2-9250-4C8E-AD25-8DC4160C6691Q31140002-C51AFED6-FAD6-4F0A-9471-F5C206492904Q33365606-6DDE818F-56E1-4B8B-9477-06981C9C00E4Q33578973-6BDCE17C-83D2-46C0-BD66-6223C0CDD65BQ33745006-9B9C00D3-725A-4229-9609-DF566F288DE4Q33833201-5804C171-F27B-46C4-A597-04ECDDCB9FC3Q33848866-25E3A325-D8E5-4B8D-98F0-CC1DD6BC1012Q33922879-BC66F278-8CB6-46BD-93E2-759B36762511Q34505106-4CADD5CA-BA45-4495-B2F1-2D26995A628EQ34547552-0E57A3C3-556E-4746-AA57-ECAF29E789F5Q35853077-24E58BC9-FC87-4B31-9BFB-D7C0DD2B2E77Q35856138-D3BE491C-5C1D-4431-BC09-FD52FA172B30Q35868052-93943133-39FF-4598-B687-61FBF9577985Q36008726-EC52FCF6-9854-41BD-99CA-2AB21C0B801AQ36065033-1AE56AC9-828A-4CFB-AA86-6A5AA96725E3Q36088247-B11796AA-0DC9-435C-8A94-A730DC16ACA2Q36210121-FA524F49-E0C4-44C3-976F-B53204F0C4CAQ36348623-92DCD84B-D261-4C5F-8D99-1BBCC8672235Q36353053-828DE3ED-CC7B-4784-AA93-3AC9CF1CEE8FQ36380800-2E167EB8-C082-4960-AA68-5F4D9A6F2C06Q36389114-B91C405D-99A0-43E7-8521-E03989B17116
P2860
Pathological mechanisms in progressive multiple sclerosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pathological mechanisms in progressive multiple sclerosis.
@en
type
label
Pathological mechanisms in progressive multiple sclerosis.
@en
prefLabel
Pathological mechanisms in progressive multiple sclerosis.
@en
P1433
P1476
Pathological mechanisms in progressive multiple sclerosis.
@en
P2093
Bruce D Trapp
Don H Mahad
P304
P356
10.1016/S1474-4422(14)70256-X
P577
2015-02-01T00:00:00Z